Skip to main content
. 2024 Jan 13;14(9):100937. doi: 10.1016/j.jpha.2024.01.005

Fig. 3.

Fig. 3

Circulation and targeting ability of macrophage membrane (Møm)-coated Prussian blue (PB) nanoparticles (MPB NPs) in the apolipoprotein E knockout (ApoE−/−) mice after i.v. administration. (A) Fluorescence images of indocyanine green (ICG)-labeled PB (PBICG) NPs and ICG-labeled Møm-coated PB (MPBICG) NPs in the serum at different time points. (B) Pharmacokinetic curves of PBICG NPs and MPBICG NPs in C57BL/6 mice. (C, D) The fluorescence images (C) and quantitative analysis (D) of the aortas of ApoE−/− mice. (E, F) The fluorescence images (E) and quantitative analysis (F) of the major organs excised from the ApoE−/− mice. Data are means ± standard deviation (SD) (n = 3). P < 0.05 vs. the PBICG group. PBS: phosphate-buffered saline; t1/2: half-life.